Assenagon Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.7M Buy
124,214
+108,181
+675% +$55.4M 0.09% 183
2026
Q1
$8.39M Buy
16,033
+10,643
+197% +$5.08M 0.01% 495
2025
Q4
$3.14M Buy
+5,390
New +$2.75M ﹤0.01% 753
2024
Q4
Sell
-969
Closed -$206K 1407
2024
Q3
$206K Sell
969
-4,862
-83% -$1.24M ﹤0.01% 1331
2024
Q2
$1.63M Sell
5,831
-7,127
-55% -$1.7M ﹤0.01% 972
2024
Q1
$3.46M Sell
12,958
-6,124
-32% -$1.44M 0.01% 704
2023
Q4
$4.42M Sell
19,082
-23,294
-55% -$4.08M 0.01% 668
2023
Q3
$6.19M Sell
42,376
-424,390
-91% -$79.9M 0.02% 520
2023
Q2
$108M Sell
466,766
-49,822
-10% -$13.5M 0.42% 46
2023
Q1
$125M Buy
516,588
+392,145
+315% +$107M 0.49% 47
2022
Q4
$36.1M Buy
124,443
+115,234
+1,251% +$11.3M 0.15% 157
2022
Q3
$598K Hold
9,209
﹤0.01% 1071
2022
Q2
$659K Buy
+9,209
New +$677K ﹤0.01% 1173
2021
Q2
Sell
-16,098
Closed -$1.88M 1327
2021
Q1
$1.88M Buy
+16,098
New +$1.88M 0.01% 724

Other funds holding MDGL